162 related articles for article (PubMed ID: 38712586)
1. Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis.
Gulubova M; Chonov D; Aleksandrova E; Ivanova K; Ignatova MM; Vlaykova T
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):233-243. PubMed ID: 38712586
[TBL] [Abstract][Full Text] [Related]
2. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
3. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.
Chang PH; Pan YP; Fan CW; Tseng WK; Huang JS; Wu TH; Chou WC; Wang CH; Yeh KY
Cancer Med; 2016 Mar; 5(3):426-33. PubMed ID: 26799163
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
Nie H; Yu Y; Wang F; Huang X; Wang H; Wang J; Tao M; Ning Y; Zhou J; Zhao Q; Xu F; Fang J
Cancer Immunol Immunother; 2024 Jun; 73(8):156. PubMed ID: 38834869
[TBL] [Abstract][Full Text] [Related]
9. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Cui G; Yuan A; Li Z; Goll R; Florholmen J
Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
[TBL] [Abstract][Full Text] [Related]
10. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
11. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
12. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.
Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M
Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
Zeng J; Tang ZH; Liu S; Guo SS
World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
[TBL] [Abstract][Full Text] [Related]
15. Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.
Miteva LD; Stanilov NS; Deliysky TS; Stanilova SA
Tumour Biol; 2014 Dec; 35(12):12655-64. PubMed ID: 25209180
[TBL] [Abstract][Full Text] [Related]
16. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 is a favorable prognostic marker for colorectal cancer.
Lin Y; Xu J; Su H; Zhong W; Yuan Y; Yu Z; Fang Y; Zhou H; Li C; Huang K
Clin Transl Oncol; 2015 Jan; 17(1):50-6. PubMed ID: 25015721
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
19. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
